New directions in plasma exchange

Current Opinion in Hematology

Volumn 10, Issue 6, 2003, Pages 424-428

  Winters, J L ^a   Pineda, A A ^a,b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Guillain Barr syndrome; Plasma exchange; Plasmapheresis; Sepsis; Wegener granulomatosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; MEDICAL LITERATURE; MEDLINE; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEGENER GRANULOMATOSIS;

GUILLAIN-BARRE SYNDROME; HUMANS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; SEPSIS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 0242361753     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200311000-00005     Document Type: Review

References (15)

1. Vamvakas EC, Pineda AA: Selective extraction of plasma constituents. In Apheresis Principles and Practice. 2nd ed. Edited by McLeod BC. Bethesda:AABB Press: publication pending.
2. Grima KM: Therapeutic apheresis in hematological and oncological diseases. J Clin Apheresis 2000, 15:28-52.
3. Winters JL, Pineda AA, McLeod BC, et al.: Therapeutic apheresis in renal and metabolic diseases. J Clin Apheresis 2000, 15:53-73.
4. Coppo P, Bussel A, Charrier S, et al.: High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Medicine (Baltimore) 2003, 82:27-38. Paper compares the efficacy of plasma exchange to large-volume plasma infusion.
5. Haas M, Leko-Mohr Z, Lang T, et al.: The LDH ratio as a marker for response to plasma exchange in HUS/TTP of the adult. Clin Nephrol 2002, 57:414-420. Describes a marker that may be useful in predicting response to plasma exchange in TTP.
6. Mori Y, Wada H, Gabazza EC, et al.: Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion 2002, 42:572-580.
7. Weinstein R: Therapeutic apheresis in neurological disorders. J Clin Apheresis 2000, 15:74-128.
8. Raphael JC, Chevret S, Hughes RA, et al.: Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2002, 2:CD001798. Comprehensive review of the randomized controlled trials of plasma exchange for Guillain-Barré syndrome. This article provides guidelines for treating patients based on these trials.
9. Lyu RK, Chen WH, Hsieh ST: Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome. Ther Apher 2002, 6:163-166. Study demonstrates an apparent inferiority of double-filtration plasmapheresis compared to plasma exchange.
10. Mori M, Kuwabara S, Fukutake T, et al.: Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases. J Neurol Neurosurg Psych 2002, 72:680. The largest case series of Miller Fisher syndrome patients treated with plasmapheresis. The study demonstrates no benefit of plasmapheresis in the treatment of this disorder.
11. Kambara C, Matsuo H, Fukudome T, et al.: Miller Fisher syndrome and plasmapheresis. Ther Apher 2002, 6:450-453.
12. Gajdos P, Chevret S, Toyka K: Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 2002, 4:CD002275. Comprehensive review of the literature on plasma exchange as a treatment for Myasthenia gravis. This paper outlines clinical situations in which plasma exchange is supported by the literature and those where additional research is needed.
13. Ataman K, Jehmlich M, Kock S, et al.: Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Med 2002, 28:1164-1167.
14. Busund R, Koukline V, Utrobin U, et al.: Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med 2002, 28:1434-1439. Large randomized trial of plasma exchange for severe sepsis and septic shock. This article suggests a possible benefit of plasma exchange in a subset of septic patients.
15. Aasarod K, Iversen BM, Hammerstrom J, et al.: Clinical outcome of patients with Wegener's granulomatosis treated with plasma exchange. Blood Purif 2002, 20:167-173. Large case series comparing plasma exchange versus immunosuppressive therapy.